About Beta-sarcoglycan-related limb-girdle muscular dystrophy R4
Beta-sarcoglycan-related limb-girdle muscular dystrophy R4 is a rare disease catalogued by Orphanet (ORPHA:119). It is associated with the SGCB gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Beta-sarcoglycan-related limb-girdle muscular dystrophy R4 trials.
Search ClinicalTrials.gov for "Beta-sarcoglycan-related limb-girdle muscular dystrophy R4" or filter by Orphanet code ORPHA:119 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Beta-sarcoglycan-related limb-girdle muscular dystrophy R4 trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Beta-sarcoglycan-related limb-girdle muscular dystrophy R4. Updated daily.